Composite endpoints and the distortion of risk-benefit analysis
- PMID: 27896848
- PMCID: PMC5237691
- DOI: 10.1111/bcp.13166
Composite endpoints and the distortion of risk-benefit analysis
References
-
- Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long‐term use of ticagrelor in patients with prior myocardial infarction. New Engl J Med 2015; 372: 1791–1800. - PubMed
-
- Lau J, Antman EM, Jimenez‐Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta‐analysis of therapeutic trials for myocardial infarction. New Engl J Med 1992; 327: 248–254. - PubMed
-
- Jarcho JA, Keaney JF. Proof that lower is better – LDL cholesterol and IMPROVE‐IT. New Engl J Med 2015; 372: 2448–2450. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources